News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astellas Pharma Inc. (JOBS) Scraps Agreement with Neurosearch A/S (DK:NEUR) on ACR16



3/4/2009 7:58:08 AM

TOKYO, March 3 (Reuters) - Astellas Pharma Inc, Japan's second-biggest drugmaker, said on Tuesday that it has scrapped its licensing agreement with a Neurosearch A/S unit on a drug to treat schizophrenia.

Read at Reuters
Read at Trading Markets.com
Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES